PharmaNet/i3 Expands Randomization and Trial Supply Management Solution
Princeton, NJ – June 21, 2012 – PharmaNet/i3, inVentiv Health’s clinical segment, and a provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, today announced a major new release of the PharmaNet/i3 Interactive Response Technologies (IRT) clinical trial randomization and supply management system. The new release expands capabilities by providing a wide array of configurable functionality for both the web (IWR) and telephone (IVR). Offered via a “Software as a Service” (SaaS) delivery model, this marks the third major release of the product which has been supporting active studies since 2010.
The new release enables sponsors to realize comprehensive randomization and supply management solutions for their trials using configurable, pre-validated software components. Rich configuration options and the ability to deploy solutions over the web and telephone provide maximum flexibility for supporting diverse clinical trial designs. The web interface is compatible with all popular web browsers and is designed to work well on computer screens as well as tablets such as the iPad.
PharmaNet/i3 is committed to providing custom IRT solutions to enable optimal study operating efficiencies and logistics. The latest release of PharmaNet/i3 IRT increases the use of pre-validated functionality while continuing to support study-specific customizations. This powerful combination shortens initial deployment schedules and supports rapid configuration changes should they be needed during the course of a study.
PharmaNet/i3’s highly experienced IRT project managers partner with clients and study teams to identify requirements for each study, and coordinate and guide the team to produce tailored solutions. IRT project managers remain the central contact for support throughout the study lifecycle in conjunction with the 24/7 support team.
“PharmaNet/i3 has been providing IRT solutions for nearly a decade and has delivered every study on-time without exception. Being part of a full service CRO, we understand the challenges study managers face during study startup. Knowing that they can count on a quality IRT system to be delivered within their timeline enables the manager and study team to focus their attention on the many other key start-up activities,” said Charles Gasman, Executive Director of Interactive Technologies, PharmaNet/i3.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
